APA (7th ed.) Citation

Jensen, I. S., Hathway, J., Cyr, P., Gauden, D., & Gardiner, P. Cost–consequence analysis of 18F-fluciclovine for the staging of recurrent prostate cancer. MDPI AG.

Chicago Style (17th ed.) Citation

Jensen, Ivar S., Joanne Hathway, Philip Cyr, David Gauden, and Peter Gardiner. Cost–consequence Analysis of 18F-fluciclovine for the Staging of Recurrent Prostate Cancer. MDPI AG.

MLA (9th ed.) Citation

Jensen, Ivar S., et al. Cost–consequence Analysis of 18F-fluciclovine for the Staging of Recurrent Prostate Cancer. MDPI AG.